Skyepharma Ag Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SKYEPHARMA AG, and what generic and branded alternatives to SKYEPHARMA AG drugs are available?
SKYEPHARMA AG has two approved drugs.
Summary for Skyepharma Ag
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Skyepharma Ag
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skyepharma Ag | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 075166-001 | Oct 7, 1999 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-002 | May 7, 2005 | BX | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-001 | May 7, 2005 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Skyepharma Ag
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-001 | May 7, 2005 | 6,696,084 | ⤷ Subscribe |
| Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-002 | May 7, 2005 | 6,696,084 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
